Skip to content

Author

Kassem Salam

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Delayed eosinophilic fasciitis following adjuvant pembrolizumab for renal cell carcinoma: a case report

Immune checkpoint inhibitors (ICIs) have significantly improved survival outcomes in various malignancies, including renal cell carcinoma (RCC). Pembrolizumab, an anti-PD-1 monoclonal antibody, is an established adjuvant therapy for high-risk localized RCC. However, ICIs are associated with a unique spectrum of i...

Kassem Salam, Sara El Meski, Mohamad Mourad et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.